A January National Review article declared “Middle-Class Philanthropy Is Collapsing,” but is that really the case? The number of donors might be declining, but gift amounts are increasing. So, is it a decline in donors or of small-dollar donations?
In this episode of the Go Beyond Fundraising Podcast, we’re taking a deeper look at this claim through the tr ... Show More
Jun 24
Unlocking Mid-Level Giving: Precision Strategies for Sustainable Growth
Your organization’s mid-level donors are already fueling your mission by giving as much as 10x more than entry-level supporters. These donors are loyal, passionate, and just one intentional moment away from becoming major givers. However, these donors often fall through the crack ... Show More
53m 52s
May 27
How Nonprofits Can Navigate Uncertainty and Emerge Stronger in 2025
The challenges have come quickly in 2025, leaving many nonprofits at risk of losing funding. Donors could be impacted, too, amid job loss, tariffs, and inflation. The next step forward may not be obvious, but one thing is clear: this is no time to stand still. On this episode of ... Show More
37m 8s
May 18
Why are Fundraising Texts SO Annoying?
Are you tired of incessant, unhinged Democratic fundraising texts and emails? Well, so are we. Tommy sits down with three experts in the party's digital fundraising space to talk about how this model became the norm, why it may be hurting Democrats more than it helps, and how tha ... Show More
1h 11m
May 2024
What Next TBD: The Dark Side of GoFundMe
In theory, crowdfunding sites offer an opportunity for anyone to give to any cause, including, say, strangers facing huge medical bills. In practice, crowdfunding suffers from many of the same inequities that led to someone needing to crowdfund to begin with.
Guest: Nora Kenworth ... Show More
32m 27s
Feb 2025
Checking In On The Housing Market… And The Future of Pharma & Health Care 2/18/25
A check in on the housing market, as builder sentiment drops to a 5-month low. The concerns they have over looming tariffs, and the latest results out of one of the top players in the space. Plus Pharma in focus, as the country’s health agencies deal with funding cuts and personn ... Show More
43m 36s